SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-073982
Filing Date
2020-06-17
Accepted
2020-06-17 07:11:42
Documents
14
Period of Report
2020-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022767d1_8k.htm   iXBRL 8-K 24373
2 EXHIBIT 99.1 tm2022767d1_ex99-1.htm EX-99.1 12723
6 GRAPHIC tm2022767d1_ex99-1img001.jpg GRAPHIC 4921
  Complete submission text file 0001104659-20-073982.txt   224595

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20200617.xsd EX-101.SCH 3210
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20200617_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20200617_pre.xml EX-101.PRE 22726
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2022767d1_8k_htm.xml XML 3729
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 20968039
SIC: 2834 Pharmaceutical Preparations